ERBB4 and neoplasm: Thus, an enhanced therapy efficiency upon HER4 knockdown could not be observed in this study, because the WT cells appeared highly sensitive ab initio; therefore, this HTM-based study reflects a prognostic impact rather than a predictive effect of HER4, at least when highly sensitive tumor cells are used.